View Older Stories View More Recent Stories

Apr 15, 2019 08:30AM International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results
Mar 4, 2019 07:00AM International Stem Cell Corporation Commences Trading on the OTCQX Best Market
Feb 13, 2019 08:30AM International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
Jan 15, 2019 08:30AM International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business
Dec 4, 2018 07:48AM Edison issues update on International Stem Cell (ISCO)
Nov 15, 2018 08:30AM International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018
Oct 8, 2018 08:30AM International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
Oct 2, 2018 08:00AM International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market
Aug 21, 2018 07:00AM International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
Aug 15, 2018 07:00AM International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018
Aug 6, 2018 07:00AM International Stem Cell Corporation Developed 3D Liver Structures
Jul 10, 2018 07:00AM International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products
Jun 25, 2018 07:00AM International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal
Jun 11, 2018 07:00AM International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
May 30, 2018 07:00AM International Stem Cell Corporation Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology
May 22, 2018 07:00AM International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
May 14, 2018 08:30AM International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
May 7, 2018 08:32AM International Stem Cell Corporation (ISCO) Secures Key Patent in US
May 7, 2018 08:30AM International Stem Cell Corporation Granted Key Patent in US
Apr 18, 2018 08:30AM International Stem Cell Corporation to Present Interim Clinical Results at the American Academy of Neurology
Apr 10, 2018 08:45AM International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
Apr 10, 2018 08:30AM International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
Mar 5, 2018 08:30AM International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial
Jan 22, 2018 08:30AM International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research
Jan 11, 2018 08:45AM International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
Jan 11, 2018 08:45AM International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
Nov 29, 2017 08:30AM International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
Nov 29, 2017 08:30AM International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
Nov 17, 2017 08:30AM International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017
Nov 13, 2017 08:30AM International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
Nov 8, 2017 08:30AM International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson's Disease at Neuroscience 2017
Oct 9, 2017 08:30AM International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
Sep 26, 2017 08:30AM International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials
Sep 20, 2017 08:30AM International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial
Sep 7, 2017 08:30AM International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease
Aug 14, 2017 08:30AM International Stem Cell Corporation Announces Operating Results for the Three and Six-Months ended June 30, 2017
May 17, 2017 08:30AM International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017
May 9, 2017 08:30AM International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson’s Disease
May 4, 2017 08:30AM International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson's Disease at the ASGCT 2017 Annual Meeting
Apr 25, 2017 08:30AM International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial
Apr 5, 2017 08:30AM International Stem Cell Corporation Announces 2016 Fourth Quarter and Year-End Results
Feb 28, 2017 08:30AM International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial
Dec 7, 2016 08:30AM International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
Nov 16, 2016 08:30AM International Stem Cell Corporation Announces Operating Results for the Three and Nine-months ended September 30, 2016
Nov 10, 2016 08:30AM International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease at the Neuroscience 2016 Conference
Oct 18, 2016 08:30AM International Stem Cell Corporation Announces Positive Efficacy Results in Traumatic Brain Injury
Oct 5, 2016 08:37AM International Stem Cell (ISCO) Announces Publication of Positive ISC-hpNSC Safety Data
Oct 5, 2016 08:30AM International Stem Cell Corporation Publishes Results of Safety Studies Conducted in Support of the First Human Pluripotent Stem Cell Based Therapy for Parkinson’s Disease
Sep 7, 2016 08:30AM International Stem Cell Corporation to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
Aug 16, 2016 08:30AM International Stem Cell Corporation Announces Operating Results for the Three and Six-Months Ended June 30, 2016
View More Recent Stories View Older Stories